粪便钙卫蛋白联合CD64指数及超敏C反应蛋白在儿童细菌性肠炎诊断中的临床价值

马亚南, 刘雯, 柴新梅, 等. 粪便钙卫蛋白联合CD64指数及超敏C反应蛋白在儿童细菌性肠炎诊断中的临床价值[J]. 中国中西医结合消化杂志, 2023, 31(9): 691-695. doi: 10.3969/j.issn.1671-038X.2023.09.07
引用本文: 马亚南, 刘雯, 柴新梅, 等. 粪便钙卫蛋白联合CD64指数及超敏C反应蛋白在儿童细菌性肠炎诊断中的临床价值[J]. 中国中西医结合消化杂志, 2023, 31(9): 691-695. doi: 10.3969/j.issn.1671-038X.2023.09.07
MA Yanan, LIU Wen, CHAI Xinmei, et al. Clinical value of fecal calprotectin combined with CD64 index and high sensitivity C-reactive protein in the diagnosis of bacterial enteritis in children[J]. Chin J Integr Tradit West Med Dig, 2023, 31(9): 691-695. doi: 10.3969/j.issn.1671-038X.2023.09.07
Citation: MA Yanan, LIU Wen, CHAI Xinmei, et al. Clinical value of fecal calprotectin combined with CD64 index and high sensitivity C-reactive protein in the diagnosis of bacterial enteritis in children[J]. Chin J Integr Tradit West Med Dig, 2023, 31(9): 691-695. doi: 10.3969/j.issn.1671-038X.2023.09.07

粪便钙卫蛋白联合CD64指数及超敏C反应蛋白在儿童细菌性肠炎诊断中的临床价值

详细信息

Clinical value of fecal calprotectin combined with CD64 index and high sensitivity C-reactive protein in the diagnosis of bacterial enteritis in children

More Information
  • 目的 探讨粪便钙卫蛋白(fecal calprotectin,FC)、CD64指数、超敏C反应蛋白(high sensitivity C-reactive protein,hs-CRP)在儿童细菌性肠炎诊断中的临床价值。方法 选取2021年1月—2022年9月徐州市儿童医院收治的100例感染性肠炎患儿为研究对象,根据肠道细菌病原学检查结果分为细菌性肠炎组(50例)和病毒性肠炎组(50例);选取同时期50例健康体检儿童作为对照组。通过受试者工作特征曲线(receiver operating characteristic curve,ROC)分析FC、CD64指数、hs-CRP及联合指标在细菌性肠炎患儿中的诊断价值。结果 细菌性肠炎组患儿的FC、CD64指数、hs-CRP显著高于对照组,差异有统计学意义(P < 0.05)。病毒性肠炎组患儿的FC、hs-CRP与对照组相比,差异有统计学意义(P < 0.05),CD64指数与对照组比较差异无统计学意义(P>0.05)。细菌性肠炎组患儿的FC、CD64指数、hs-CRP显著高于病毒性肠炎组,差异有统计学意义(P < 0.05)。ROC曲线显示,FC、CD64指数、hs-CRP诊断细菌性肠炎患儿的ROC曲线下面积(area under the curve,AUC)分别是0.881、0.969、0.792;FC+CD64指数和FC+hs-CRP双项联合检测时AUC分别是0.969、0.884;FC+CD64指数+hs-CRP联合检测时AUC为0.967。通过比较发现,FC+hs-CRP与FC+hs-CRP+CD64指数的AUC差异有统计学意义(P < 0.05),而FC+CD64指数与FC+hs-CRP+CD64指数差异无统计学意义(P>0.05)。结论 FC+CD64指数联合检测以及FC+CD64指数+hs-CRP联合检测均能有效判断细菌性肠炎患儿,且诊断价值相当。基于简便性及成本考虑,临床上更推荐使用FC+CD64指数联合检测。
  • 加载中
  • 图 1  FC、CD64指数、hs-CRP单项和联合检测判断细菌性肠炎的ROC曲线

    表 1  3组FC、CD64指数、hs-CRP水平的比较 X±S

    组别 例数 FC/(μg/g) CD64指数 hs-CRP/(mg/L)
    对照组 50 36.28±0.90 0.07±0.01 0.63±0.08
    病毒性肠炎组 50 53.85±6.411) 0.11±0.02 11.52±3.241)
    细菌性肠炎组 50 145.25±14.821) 0.41±0.031) 31.61±6.281)
    与对照组比较,1)P < 0.05。
    下载: 导出CSV

    表 2  FC、CD64指数、hs-CRP单项检测和联合检测对细菌性肠炎的诊断价值

    指标 AUC 最佳截断值 95%CI P 灵敏度 特异度
    FC 0.881 55.84 μg/g 0.818~0.945 < 0.001 0.80 0.90
    CD64指数 0.969 0.155 0.942~0.996 < 0.001 1.00 0.92
    hs-CRP 0.792 2.15 mg/L 0.717~0.868 < 0.001 0.82 0.65
    FC+CD64指数 0.969 0.943~0.995 < 0.001 1.00 0.90
    FC+hs-CRP 0.884 0.822~0.946 < 0.001 0.86 0.83
    FC+CD64指数+hs-CRP 0.967 0.941~0.994 < 0.001 1.00 0.89
    下载: 导出CSV
  • [1]

    李丹, 汪剑晖, 艾红红, 等. 血清中性粒细胞载脂蛋白在儿童感染性腹泻中的鉴别诊断价值[J]. 检验医学与临床, 2020, 17(8): 1107-1109. doi: 10.3969/j.issn.1672-9455.2020.08.028

    [2]

    林声, 宫霄欢, 肖文佳, 等. 2016—2021年上海市儿童感染性腹泻哨点监测分析[J]. 中华流行病学杂志, 2023, 44(2): 243-249. doi: 10.3760/cma.j.cn112338-20220417-00667

    [3]

    周林, 李静, 除文健, 等. 首都儿科研究所附属儿童医院门诊感染性腹泻患儿的细菌病原学分析[J]. 中华检验医学杂志, 2019, 42(5): 359-364. doi: 10.3760/cma.j.issn.1009-9158.2019.05.008

    [4]

    Hor JW, Lim SY, Khor ES, et al. Fecal calprotectin in parkinson's disease and multiple system atrophy[J]. J Mov Disord, 2022, 15(2): 106-114. doi: 10.14802/jmd.21085

    [5]

    Ardelean MV, Kundnani NR, Sharma A, et al. Fecal calprotectin-a valuable predictor of microscopic colitis[J]. Eur Rev Med Pharmacol Sci, 2022, 26(24): 9382-9392.

    [6]

    Khaki-Khatibi F, Qujeq D, Kashifard M, et al. Calprotectin in inflammatory bowel disease[J]. Clin Chim Acta, 2020, 510: 556-565. doi: 10.1016/j.cca.2020.08.025

    [7]

    赵莺, 徐锦. 粪便钙卫蛋白在儿童炎症性肠病中的临床意义[J]. 检验医学, 2022, 37(5): 429-432. doi: 10.3969/j.issn.1673-8640.2022.05.006

    [8]

    宁萌. 粪便钙卫蛋白对溃疡性结肠炎病情活动的评估价值[D]. 沈阳: 中国医科大学, 2020.

    [9]

    Levinson T, Wasserman A. C-reactive protein velocity(CRPv)as a new biomarker for the early detection of acute infection/inflammation[J]. Int J Mol Sci, 2022, 23(15): 8100. doi: 10.3390/ijms23158100

    [10]

    de Fraiture EJ, Vrisekoop N, Leenen LPH, et al. Longitudinal assessment of the inflammatory response: the next step in personalized medicine after severe trauma[J]. Front Med(Lausanne), 2022, 9: 983259.

    [11]

    Gao YT, Lin LH, Zhao JY, et al. Neutrophil CD64 index as a superior indicator for diagnosing, monitoring bacterial infection, and evaluating antibiotic therapy: a case control study[J]. BMC Infect Dis, 2022, 22(1): 892. doi: 10.1186/s12879-022-07725-4

    [12]

    冯莉莉, 屈晓威, 貌彦昀. 外周血CD64指数和血清淀粉样蛋白A检测在学龄前儿童细菌感染诊断中的临床意义[J]. 河北医学, 2021, 27(12): 2039-2043. doi: 10.3969/j.issn.1006-6233.2021.12.023

    [13]

    田宇, 马梦影, 辛娜, 等. 血清核转录因子-κB及CD64诊断细菌性感染疾病的价值[J]. 实用临床医药杂志, 2022, 26(19): 71-75. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202219015.htm

    [14]

    Lee HW, Han SB, Rhim JW. Application of a multiplex polymerase chain reaction test for diagnosing bacterial enteritis in children in a real-life clinical setting[J]. Children(Basel), 2021, 8(7): 538.

    [15]

    沙丹, 肖勇, 李泓, 等. 腹泻病原在儿童中的感染流行特征及耐药性分析[J]. 中国卫生检验杂志, 2020, 30(24): 2981-2983, 2987. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ202024011.htm

    [16]

    Kasai Y, Komatsu M, Toyama Y, et al. Characteristics and antimicrobial choice of pediatric bacterial enteritis in the Kanto region of Japan: a multicenter retrospective observational study[J]. J Infect Chemother, 2022, 28(6): 723-728. doi: 10.1016/j.jiac.2021.08.022

    [17]

    Yang JJ, Lee KS. Epidemiologic changes in over 10 years of community-acquired bacterial enteritis in children[J]. Pediatr Gastroenterol Hepatol Nutr, 2022, 25(1): 41-51. doi: 10.5223/pghn.2022.25.1.41

    [18]

    李王强, 陈必全. 细菌性肠炎病患儿病原菌分布及药敏结果分析[J]. 现代消化及介入诊疗, 2020, 25(1): 37-40. doi: 10.3969/j.issn.1672-2159.2020.01.008

    [19]

    黄卫春, 潘秋辉, 曹清, 等. 2016至2020年上海某三甲儿童专科医院细菌性肠炎病原菌及其临床特征分析[J]. 中国小儿急救医学, 2022, 29(11): 891-894. doi: 10.3760/cma.j.issn.1673-4912.2022.11.008

    [20]

    Kawashima K, Oshima N, Kishimoto K, et al. Low fecal calprotectin predicts histological healing in patients with ulcerative colitis with endoscopic remission and leads to prolonged clinical remission[J]. Inflamm Bowel Dis, 2023, 29(3): 359-366. doi: 10.1093/ibd/izac095

    [21]

    Shimizu H, Ebana R, Kudo T, et al. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease[J]. J Gastroenterol, 2022, 57(5): 344-356. doi: 10.1007/s00535-022-01856-w

    [22]

    Lee YM, Choi S, Choe BH, et al. Association between fecal calprotectin and mucosal healing in pediatric patients with crohn's disease who have achieved sustained clinical remission with anti-tumor necrosis factor agents[J]. Gut Liver, 2022, 16(1): 62-70. doi: 10.5009/gnl20300

    [23]

    嵇金陵, 张小云, 王宏刚, 等. 炎症性肠病患者粪便钙卫蛋白水平分析[J]. 临床检验杂志, 2021, 39(11): 839-840. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJY202111009.htm

    [24]

    Capkin E, Kurt H, Gurel B, et al. Characterization of FcγRIa(CD64) as a ligand molecule for site-specific IgG1 capture: a side-by-side comparison with protein A[J]. Langmuir, 2022, 38(48): 14623-14634. doi: 10.1021/acs.langmuir.2c02022

    [25]

    Patnaik R, Azim A, Agarwal V. Neutrophil CD64 a diagnostic and prognostic marker of Sepsis in adult critically ill patients: a brief review[J]. Indian J Crit Care Med, 2020, 24(12): 1242-1250. doi: 10.5005/jp-journals-10071-23558

    [26]

    Cao LL, Wang WW, Zhao L, et al. Neutrophil CD64 index for diagnosis of infectious disease in the pediatric ICU: a single-center prospective study[J]. BMC Pediatr, 2022, 22(1): 718. doi: 10.1186/s12887-022-03738-9

    [27]

    Kang DO, Park Y, Seo JH, et al. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction[J]. J Cardiol, 2019, 74(1): 74-83.

    [28]

    马继荣, 沈薇, 顾怡, 等. 粪钙卫蛋白、C反应蛋白、白介素-6在诊断克罗恩病患者消化道黏膜损伤状态中的价值[J]. 上海交通大学学报(医学版), 2022, 42(3): 331-336. https://www.cnki.com.cn/Article/CJFDTOTAL-SHEY202203010.htm

  • 加载中

(1)

(2)

计量
  • 文章访问数:  448
  • PDF下载数:  107
  • 施引文献:  0
出版历程
收稿日期:  2023-02-16
刊出日期:  2023-09-15

目录